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Abstract Intraoperative examination of sentinel axillary
lymph nodes can be done by imprint cytology, frozen
section, or, most recently, by PCR-based amplification of a
cytokeratin signal. Using this technique, benign epithelial
inclusions, representing mammary tissue displaced along
the milk line, will likely generate a positive PCR signal and
lead to a false-positive diagnosis of metastatic disease. To
better appreciate the incidence of ectopic epithelial inclu-
sions in axillary lymph nodes, we have performed an
autopsy study, examining on 100 lm step sections 3,904
lymph nodes obtained from 160 axillary dissections in 80
patients. The median number of lymph nodes per axilla
was 23 (15, 6, and 1 in levels 1, 2, and 3, respectively). A
total of 30,450 hematoxylin-eosin stained slides were
examined, as well as 8,825 slides immunostained with pan-
cytokeratin antibodies. Despite this meticulous work-up,
not a single epithelial inclusion was found in this study,
suggesting that the incidence of such inclusions is much
lower than the assumed 5% reported in the literature.
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Introduction
Removing metastatic axillary lymph nodes is currently
considered standard of care in patients with invasive breast
carcinoma. Intraoperative examination of the sentinel
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lymph node by frozen section or imprint cytology allows to
decide on the spot who should benefit from immediate
axillary dissection (in case of a metastasis in the sentinel
lymph node) or who can be spared this procedure and
hence the risk of lymph edema. However, due to technical
limitations and time constraints, intra-operative sentinel
node examination suffers from a rather high false-nega-
tivity rate, resulting in re-operations in a substantial num-
ber of patients [1, 2].
An alternative to the microscopic search for nests of
cytologically atypical tumor cells is the search for cyto-
keratin signatures by polymerase chain reaction (PCR) in
homogenized lymph nodes [3]. Using quantitative real time
(RT)-PCR, cut-offs have been defined which should allow
to differentiate between ‘‘irrelevant’’ isolated tumor cells/
sub-micrometastases (\200 lm) and ‘‘relevant’’ metasta-
ses (micro-metastases and metastases; Ref. [3]). At least
two different companies are now marketing the PCR-based
technology for intraoperative examination of sentinel
lymph nodes (GeneSearch from Veridex, Raritan, NJ and
OSNA from Sysmex, Norderstedt, Germany).
Ectopic epithelial tissue/benign glandular inclusions in
lymph nodes can occasionally lead to diagnostic surprise
and confusion. Not infrequently, salivary gland and thyroid
fragments are found in cervical lymph nodes and melano-
cytic nevus cells in axillary and inguinal nodes [4]. Ana-
tomical pathologists occasionally encounter ectopic breast
tissue, embryologic remnants of the milk line, in the axil-
lary fat as well as in the capsule and parenchyma of axil-
lary lymph nodes [5–9]. It stands to reason that these
ectopic epithelial elements will be recognized by intraop-
erative PCR and hence interpreted as metastasis. Indeed,
one recent prospective study comparing intraoperative
PCR and imprint cytology on alternating slices of axillary
nodes identified one case where a positive PCR signal
could be matched to ectopic breast tissue and not to a
metastasis [9]. Unfortunately, once performed as the sole
technique—outside of comparative studies—there will be
no possibility to verify the malignant nature of the intra-
operative PCR signal, because the lymph node is homog-
enized for the technique and hence no longer available for
microscopic analysis.
For this reason, we thought that it would be important to
know how frequently these ectopic epithelial inclusions are
to be found in axillary nodes, hence how often patients have
to expect being falsely diagnosed with metastatic disease by
PCR technology. While ectopic epithelial inclusions have
been described in case reports or a few mini-series [5–7], not
a single study has ever addressed the incidence of such
inclusions in a systematic fashion. Therefore, we have set out
to quantify the presence of epithelial inclusions in 3,904
axillary lymph nodes removed during post-mortem exam-
inations of patients without breast carcinoma.
Methods
This is an autopsy study that has examined the presence of
ectopic epithelial inclusions in axillary lymph nodes. The
study was performed on 80 patients (34 female and 46 male)
who underwent consecutive medical post-mortem exami-
nation in the Department of Pathology at the Johannes
Gutenberg University of Mainz, Medical school, during the
period of 3/2002–6/2003. The mean age was 67.4 ± 14.2
and 63.9 ± 14.2 years for female and male patients,
respectively, and the body mass index was 23.0 ± 3.6 and
26.9 ± 3.6. Patients had died of cerebro- and cardiovascular
diseases (23 female and 27 male patients), followed by
sepsis (6 female and 10 male patients), and the immediate
consequence of malignant tumors (5 female and 8 male
patients). 17 female and 18 male patients had malignant
tumors, but which were not the immediate cause of death.
None of the patients had undergone axillary dissection for
breast carcinoma or for other reasons.
The study was performed in accordance to existing
institutional guidelines. The use of tissue obtained during
medical autopsies for research was specifically mentioned in
the general covenant that patients signed upon entry into the
hospital (http://www.unimedizin-mainz.de/index.php?id=
1741#c36971) and also specifically stipulated in the docu-
ment that family members signed as part of the consent to
autopsy procedure. The study was performed entirely within
the institute of pathology. No patient identifiers were used.
No modification of the standard medical autopsy procedure
was necessary as bilateral axillary lymph nodes could be
accessed through the standard ventral Y-incision of throrax
and abdomen.
Following instruction and under supervision by a board-
certified gynaecological surgeon (PD Dr. Marcus Schmidt),
the axillary fat with the lymph nodes was removed
according to standard procedures, following well-estab-
lished anatomical landmarks, thus separating the levels 1,
2, and 3. The fat removed from each level was weighed,
fixed for 24 h in buffered formaldehyde (4%), and finally
dissected for the isolation of individual lymph nodes.
Holding the lymph nodes gently between two fingers, slices
of 0.2 cm were placed perpendicular to the smallest
diameter, and embedded in one histocassette, if possible.
Smaller lymph nodes were embedded with other lymph
nodes up to a maximum of ten lymph nodes per histocas-
sette. Three 4 lm sections were cut every 100 lm across
the entire lymph node and mounted on either normal glass
slides for later hematoxylin-eosin (H&E) stains according
to standard protocol, or on poly L-lysine-pretreated glass
slides for immunohistochemistry. Immunohistochemistry
was performed on lymph nodes (all levels) of ten male and
ten female patients, chosen at random prior to the exami-
nation of H&E sections. For that purpose, we applied a
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pan-cytokeratin antibody (clone MNF116, DAKO, Car-
pinteria, CA; dilution 1:100), which covers a wide spec-
trum of cytokeratins (cytokeratins 5, 6, 8, 17, 19).
The widest diameters (length and width) of each lymph
node were measured on the H&E slide. Lymph nodes were
then examined using a standard diagnostic microscope and
all abnormalities were recorded, placing particular
emphasis on the presence of ectopic epithelial inclusions.
Results
A total of 3,904 lymph nodes were isolated from the 160
axillary dissections (bilateral axillary dissections in each
patient). We counted a median of 23 lymph nodes per
axilla (mean ± SD: 24.6 ± 10.9). In the median, 15, 6, and
1 lymph nodes were counted in the levels 1, 2, and 3,
respectively (mean ± SD: 16.1±7.5; 6.9±5.1; 1.6±2.1).
There was no significant difference between the number of
lymph nodes found in male and female patients, and
between right-sided and left-sided axillas (not shown). The
average maximal diameters of the lymph nodes was
0.60 ± 0.09 cm (length, mean ± SD) and 0.35 ± 0.05 cm
(width, mean ± SD), with no difference between male and
female patients and between left-sided and right-sided ax-
illas (not shown). However, maximal lymph node size was
larger in level 1 (0.68 ± 0.14 cm 9 0.40 ± 0.09 cm) then
in level 2 (0.48 ± 0.11 cm 9 0.29 ± 0.07 cm) and in
level 3 (0.36 ± 0.18 cm 9 0.22 ± 0.08 cm). This differ-
ence was statistically significant (P \ 0.01, Wilcoxon). Of
the 3,904 lymph nodes, we obtained a median of eight
sections at 100 lm distance, ranging from 3 to a maximum
of 16. In this way, a total of 30,450 slides were examined
by standard H&E and 8,825 slides by immunohistochem-
istry (corresponding to 1,102 lymph nodes of ten male and
ten female patients).
Upon histological examination of the lymph nodes, the
following abnormalities were noted, in decreasing order of
frequency: sinus histiocytosis (57.4%), focal scarring
(41.7%), hyaline fibrosis (33.9%), lipomatous transforma-
tion (31.0%), and fibrous thickening of the capsule (7.6%).
39 lymph nodes in four patients contained metastases of
non-mammary origin: one metastatic neuroendocrine car-
cinoma of small intestinal origin, one primary bronchial
carcinoma, one melanoma, and one Non-Hodgkin lym-
phoma. In all these cases, the association of the lymph node
metastasis with the primary tumor was confirmed by
standard histology or by immunohistochemistry. After
histological examination of H&E stained sections of 3,904
lymph nodes, totalling 30,450 slides, we could not find a
single focus of ectopic epithelial inclusion, neither within
the lymph node parenchyma, nor in the capsule or in the
peri-nodal adipose tissue. Neither did we identify any
cytokeratin-positive epithelial cells in a total of 1,102
lymph nodes subjected to immunohistochemical examina-
tion on serial sections (8,825 slides).
Discussion
The principal finding of this study is that not a single focus
of ectopic epithelial inclusion was found in almost 4,000
investigated lymph nodes. This finding was unexpected
since the incidence of supra-numerary breast tissue in the
axilla has been estimated at 5–6% [5, 10]. If these figures
were correct, we should have found inclusions in at least
four patients. Based on this assumption, the chance to not
find a single ectopic epithelial inclusion in our population
of 80 patients can be calculated at P \ 0.02 by binomial
distribution. We hence believe that our study is sufficiently
powered to suggest that epithelial cell inclusions are much
rarer than the 5% estimated in the existent literature.
Maiorano and coworkers [6] reported on seven foci of
ectopic epithelial inclusions in sentinel axillary lymph
nodes. Four of these cases had been in-house cases found
among a total of 3,500 sentinel lymph nodes and three cases
were consultations. Based on these numbers, a rough inci-
dence of 0.1% can be estimated, which would still be far from
the 5% reported in the literature. While it may be speculated
that epithelial inclusions are somewhat more frequent in
sentinel nodes because of their privileged position for a
potential embryologic nodal entrapment, there currently
exists no data to support this hypothesis. Based on the finding
of our study and the data reported by Maiorano and
coworkers, we believe that a figure of roughly 0.1% can
safely be assumed as a reasonably correct figure when
counselling patients about the risk of a false-positive PCR
signal during intraoperative sentinel node examination.
The number of lymph nodes found in our autopsy series
(median: 23 lymph nodes) corresponds rather well with
data reported before for axillary dissections in alive
patients: an average of around 19 lymph nodes per axilla
were reported by Turner and coworkers [11], 27 lymph
nodes by Viale and coworkers [12], and 23–26 lymph
nodes by Cappello and coworkers [13]. In contrast to a
previous publication by Misnik [14], we could not confirm
that the number of lymph nodes per axilla increased with
the age of the patients: we found an average of 25 lymph
nodes in 38 patients under the age of 65 and 22 lymph
nodes in 42 patients above the age of 65.
Conclusion
In conclusion, we have to acknowledge that not a single
epithelial inclusion was found in this prospective series of
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3,904 meticulously examined axillary lymph nodes in non-
breast cancer patients. While we are very well aware that
3,904 axillary lymph nodes in 80 patients is not the same as
3,904 sentinel lymph nodes in 3,904 patients, we believe
that our study is of relevance since it helps to better
appreciate the frequency of epithelial inclusions in axillary
nodes of breast cancer patients and also the risk of putative
false-positive results in PCR-based intraoperative sentinel
node examination, as a basis for treatment decisions and
patient counselling.
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